Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
S. Nasir
Observed name:
S Nasir
Institution:
GlaxoSmithKline (United Kingdom)
Observed institution:
GlaxoSmithKline (United Kingdom)
ORCID:
0009-0001-0839-9058
Observed ORCID:
0009-0001-0839-9058
OpenAlex ID:
A5088288221
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
2000
·
D Smart
, M J Gunthorpe
, et al.
·
British Journal of Pharmacology
·
850
PDF
The distribution of the mRNA and protein products of the melanin‐concentrating hormone (MCH) receptor gene, slc‐1, in the central nervous system of the rat
2000
·
G. J. Hervieu
, J. E. Cluderay
, et al.
·
European Journal of Neuroscience
·
327
Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist
2003
·
M.J. Gunthorpe
, H.K. Rami
, et al.
·
Neuropharmacology
·
293
The neuroprotective agent sipatrigine (BW619C89) potently inhibits the human tandem pore-domain K+ channels TREK-1 and TRAAK
2001
·
H.J. Meadows
, C.G. Chapman
, et al.
·
Brain Research
·
63
Erratum to “Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist” [Neuropharmacology 46 (2004) 133–149]
2004
·
M.J. Gunthorpe
, H.K. Rami
, et al.
·
Neuropharmacology
·
3
Show more works
View as search
Works count:
5
Citation count:
1,536
H-index:
4
I10-index:
4
Year
Topic
Type